What's breaking now, across thousands of outlets.
Biopharma earnings season is also pipeline update season. On Thursday, Takeda, Regeneron, Sanofi and Bristol Myers Squibb all announced program cuts as part of their quarterly updates. Some of the terminations were for early-stage programs: ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
Dietary arginine reduces tumor formation and viral load in mice by boosting key immune proteins.
[UCT] Asymptomatic tuberculosis (TB) is common and biologically more complex than previously understood, with implications for treatment and care strategies.
[IPS] United Nations -- The Democratic Republic of Congo (DRC) is battling the fastest-growing Ebola outbreak on record, with United Nations officials warning that hunger is actively undermining…
More details have emerged about how the industry’s largest psychedelic biotech buyout came to fruition. In an SEC filing on Thursday morning, AtaiBeckley disclosed some of the play-by-play from its
Pfizer reports Phase 3 wins for Litfulo: The drug succeeded in two trials for active and stable nonsegmental vitiligo, an autoimmune condition that causes skin to progressively lose its color. One ...
A new study finds that ocean temperatures thousands of kilometers away shape soil moisture in Malawi, offering a potential tool for forecasting malaria outbreaks months in advance.
